Jerzy Kleps

569 total citations
32 papers, 486 citations indexed

About

Jerzy Kleps is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Jerzy Kleps has authored 32 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 16 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Jerzy Kleps's work include Synthesis and Reactivity of Heterocycles (14 papers), Synthesis and Biological Evaluation (11 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (10 papers). Jerzy Kleps is often cited by papers focused on Synthesis and Reactivity of Heterocycles (14 papers), Synthesis and Biological Evaluation (11 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (10 papers). Jerzy Kleps collaborates with scholars based in Poland. Jerzy Kleps's co-authors include Franciszek Herold, Maciej Dawidowski, Jadwiga Turło, Gabriel Nowak, Eliza Malinowska, Marek Król, Piotr Suchocki, Marian Olejnik, Wojciech Krzyczkowski and Agata Siwek and has published in prestigious journals such as Food Chemistry, International Journal of Molecular Sciences and Carbohydrate Polymers.

In The Last Decade

Jerzy Kleps

32 papers receiving 467 citations

Peers

Jerzy Kleps
Jerzy Kleps
Citations per year, relative to Jerzy Kleps Jerzy Kleps (= 1×) peers Maciej Dawidowski

Countries citing papers authored by Jerzy Kleps

Since Specialization
Citations

This map shows the geographic impact of Jerzy Kleps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy Kleps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy Kleps more than expected).

Fields of papers citing papers by Jerzy Kleps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerzy Kleps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy Kleps. The network helps show where Jerzy Kleps may publish in the future.

Co-authorship network of co-authors of Jerzy Kleps

This figure shows the co-authorship network connecting the top 25 collaborators of Jerzy Kleps. A scholar is included among the top collaborators of Jerzy Kleps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerzy Kleps. Jerzy Kleps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Król, Marek, Jerzy Kleps, Szymon Ulenberg, et al.. (2021). Synthesis of Novel Pyrido[1,2-c]pyrimidine Derivatives with 6-Fluoro-3-(4-piperidynyl)-1,2-benzisoxazole Moiety as Potential SSRI and 5-HT1A Receptor Ligands. International Journal of Molecular Sciences. 22(5). 2329–2329. 11 indexed citations
2.
Król, Marek, Jerzy Kleps, Piotr Podsadni, et al.. (2019). Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT1A receptor ligands. European Journal of Medicinal Chemistry. 180. 383–397. 11 indexed citations
3.
Król, Marek, Jerzy Kleps, Szymon Ulenberg, et al.. (2019). Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT1A receptor ligands. European Journal of Medicinal Chemistry. 166. 144–158. 16 indexed citations
4.
Malinowska, Eliza, Tomasz Strączek, Krystyna Schneider, et al.. (2018). Selenized polysaccharides – Biosynthesis and structural analysis. Carbohydrate Polymers. 198. 407–417. 67 indexed citations
5.
Kleps, Jerzy, Maciej Dawidowski, Agata Siwek, et al.. (2015). Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. Part 5. European Journal of Medicinal Chemistry. 98. 221–236. 16 indexed citations
6.
Turło, Jadwiga, Jerzy Kleps, Agata Siwek, et al.. (2014). Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. Part 4. European Journal of Medicinal Chemistry. 90. 21–32. 15 indexed citations
7.
Herold, Franciszek, Jerzy Kleps, Aleksander P. Mazurek, et al.. (2013). Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1. European Journal of Medicinal Chemistry. 63. 484–500. 36 indexed citations
9.
Dawidowski, Maciej, et al.. (2011). Synthesis and anticonvulsant activity of novel 2,6-diketopiperazine derivatives. Part 2: Perhydropyrido[1,2-a]pyrazines. European Journal of Medicinal Chemistry. 48. 347–353. 20 indexed citations
10.
Dawidowski, Maciej, Jerzy Kleps, Stanisław J. Czuczwar, et al.. (2011). Synthesis and biological investigation of potential atypical antipsychotics with a tropane core. Part 1. European Journal of Medicinal Chemistry. 46(9). 4474–4488. 13 indexed citations
11.
Dawidowski, Maciej, et al.. (2011). Synthesis and anticonvulsant activity of novel 2,6-diketopiperazine derivatives. Part 1: Perhydropyrrole[1,2-a]pyrazines. European Journal of Medicinal Chemistry. 46(10). 4859–4869. 35 indexed citations
12.
Herold, Franciszek, Jadwiga Turło, Maciej Dawidowski, et al.. (2010). Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. part 3. European Journal of Medicinal Chemistry. 46(1). 142–149. 28 indexed citations
13.
Herold, Franciszek, Maciej Dawidowski, Marek Król, et al.. (2009). Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: Part 2☆. European Journal of Medicinal Chemistry. 44(11). 4702–4715. 13 indexed citations
14.
Herold, Franciszek, Marek Król, Jerzy Kleps, et al.. (2008). Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity, Part 1. European Journal of Medicinal Chemistry. 44(4). 1710–1717. 14 indexed citations
15.
Krzyczkowski, Wojciech, Eliza Malinowska, Piotr Suchocki, et al.. (2008). Isolation and quantitative determination of ergosterol peroxide in various edible mushroom species. Food Chemistry. 113(1). 351–355. 75 indexed citations
16.
Laudy, Agnieszka E., et al.. (2008). Synthesis of 1-{4-[4-(adamant-1-yl)phenoxymethyl]-2-(4-bromophenyl)- 1,3-dioxolan-2-ylmethyl}imidazole with expected antifungal and antibacterial activity.. PubMed. 64(6). 535–41. 9 indexed citations
17.
Herold, Franciszek, Marek Król, Jerzy Kleps, & Gabriel Nowak. (2005). Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4. European Journal of Medicinal Chemistry. 41(1). 125–134. 12 indexed citations
18.
Maciejewska, Dorota, Jacek Jakowski, Jerzy Kleps, & Grzegorz Chałasiński. (2004). Conformational analysis of N-benzyl-N-o-tolyl-p-methylbenzene-sulfonamides from dynamic 1H NMR experiments and theoretical calculations. Journal of Molecular Structure THEOCHEM. 680(1-3). 5–13. 3 indexed citations
19.
Herold, Franciszek, Jerzy Kleps, I. Wolska, & Gabriel Nowak. (2002). Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Il Farmaco. 57(12). 959–971. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026